| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |